Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2013-11-02
Original market date: See footnote 1
1993-12-31
Product name:
CLINIMIX
Description:
5% AMINO ACIDS (BLEND B) WITHOUT ELECTROLYTES IN 5% DEXTROSE INJECTION
DIN:
02013886
Product Monograph/Veterinary Labelling:
Date:
2022-04-01
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
15
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BA10 COMBINATIONS
Active ingredient group (AIG) number:See footnote5
1550853015
Active ingredient(s) See footnote8 | Strength |
---|---|
DEXTROSE | 5 G / 100 ML |
GLYCINE | 1.04 G / 100 ML |
HISTIDINE | 220 MG / 100 ML |
L-ALANINE | 1.04 G / 100 ML |
L-ARGININE | 520 MG / 100 ML |
L-ISOLEUCINE | 240 MG / 100 ML |
L-LEUCINE HYDROCHLORIDE | 310 MG / 100 ML |
L-LYSINE HYDROCHLORIDE | 290 MG / 100 ML |
L-PHENYLALANINE HYDROCHLORIDE | 310 MG / 100 ML |
L-PROLINE | 210 MG / 100 ML |
L-THREONINE | 210 MG / 100 ML |
L-TYROSINE | 20 MG / 100 ML |
L-VALINE | 230 MG / 100 ML |
METHIONINE | 290 MG / 100 ML |
TRYPTOPHAN | 90 MG / 100 ML |